Prestons Super Show

Inside Eli Lilly's $1.2 Billion Deal with Ventyx Biosciences


Listen Later

Eli Lilly Purchases Ventyx Biosciences for $1.2 billion. Ventyx Biosciences is advancing a gallimaufry of treatments. Including but not limited to, oral therapies for inflammatory bowel diseases. Thank you for listening. Visit myoddman.com and subscribe for more! Super News #122.

...more
View all episodesView all episodes
Download on the App Store

Prestons Super ShowBy Preston Olson

  • 5
  • 5
  • 5
  • 5
  • 5

5

2 ratings